SpringerLink
Log in

Which Margin Should Be Added to the GTV?

  • Chapter
  • First Online:
Multidisciplinary Management of Rectal Cancer

  • 984 Accesses

Abstract

During the past decennium, precision of radiotherapy treatment has increased with the implementation of highly-conformal radiotherapy techniques. The steep dose gradients of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) demand precisely defined target volumes and margins.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. ICRU (1993) Prescribing, recording, and reporting photon beam therapy. ICRU Report 50, International Commission on Radiation Units and Measurements. ICRU, Bethesda

    Google Scholar 

  2. Appelt AL, Ploen J, Vogelius IR, Bentzen SM, Jakobsen A (2013) Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 85(1):74–80

    Article  PubMed  Google Scholar 

  3. Lezoche F, Baldarelli M, Guerrieri M et al (2008) A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22(2):352–358

    Article  CAS  PubMed  Google Scholar 

  4. Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4):711–717

    PubMed  PubMed Central  Google Scholar 

  5. Beets-Tan RG, Beets GL, Vliegen RF et al (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357(9255):497–504

    Article  CAS  PubMed  Google Scholar 

  6. Tan J, Lim Joon D, Fitt G et al (2010) The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study. J Med Imaging Radiat Oncol 54(6):562–568

    Article  CAS  PubMed  Google Scholar 

  7. O’Neill BD, Salerno G, Thomas K, Tait DM, Brown G (2009) MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. Br J Radiol 82(978):509–513

    Article  PubMed  Google Scholar 

  8. Buijsen J, van den Bogaard J, Janssen MH et al (2011) FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer. Radiother Oncol 98(2):270–276

    Article  PubMed  Google Scholar 

  9. Braendengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B (2011) Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study. Int J Radiat Oncol Biol Phys 81(4):e439–e445

    Article  PubMed  Google Scholar 

  10. Roels S, Slagmolen P, Nuyts J et al (2008) Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG? Acta Oncol 47(7):1237–1248

    Article  CAS  PubMed  Google Scholar 

  11. Roels S, Slagmolen P, Nuyts J et al (2009) Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls. Int J Radiat Oncol Biol Phys 75(3):782–790

    Article  PubMed  Google Scholar 

  12. Krengli M, Cannillo B, Turri L et al (2010) Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging. Technol Cancer Res Treat 9(4):393–398

    Article  PubMed  Google Scholar 

  13. Patel DA, Chang ST, Goodman KA et al (2007) Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. Technol Cancer Res Treat 6(1):31–36

    Article  PubMed  Google Scholar 

  14. Buijsen J, van den Bogaard J, van der Weide H et al (2012) FDG-PET-CT reduces the interobserver variability in rectal tumour delineation. Radiother Oncol 102(3):371–376

    Article  PubMed  Google Scholar 

  15. Nuyttens JJ, Robertson JM, Yan D, Martinez A (2002) The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 53(2):497–503

    Article  PubMed  Google Scholar 

  16. Vorwerk H, Liersch T, Rothe H et al (2009) Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer. Strahlenther Onkol 185(2):127–133

    Article  PubMed  Google Scholar 

  17. Hollmann B, Nijkamp J, Sonke J, Marijnen C (2012) Positional variation on involved mesorectal lymph nodes during RT of rectal cancer. Radiother Oncol 103(1):S181

    Article  Google Scholar 

  18. Roels S, Duthoy W, Haustermans K et al (2006) Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65(4):1129–1142

    Article  PubMed  Google Scholar 

  19. Joye I, Haustermans K (2015) Clinical target volume delineation for rectal cancer radiation therapy: time for updated guidelines? Int J Radiat Oncol Biol Phys 91(4):690–691

    Article  PubMed  Google Scholar 

  20. Myerson RJ, Garofalo MC, El Naga I et al (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74(3):824–830

    Article  PubMed  Google Scholar 

  21. Belgian Procare Workgroup (2006) Multidisciplinary guidelines for the treatment of rectal cancer. www.belsurg.org/belsurg.html, pp 14–15

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    K. Haustermans & I. Joye

Authors
  1. K. Haustermans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Joye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Haustermans .

Editor information

Editors and Affiliations

  1. Dept. of Radiation Oncology, Università Cattolica S Cuore, Rome, Italy

    Vincenzo Valentini

  2. Head, Div. Clinical Oncology Research, University Clinic Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany

    Hans-Joachim Schmoll

  3. Department of Surgery, Leiden Univ Med Ctr, Leiden, The Netherlands

    Cornelis J. H. van de Velde

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag Berlin Heidelberg

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Haustermans, K., Joye, I. (2018). Which Margin Should Be Added to the GTV?. In: Valentini, V., Schmoll, HJ., van de Velde, C. (eds) Multidisciplinary Management of Rectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-43217-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43217-5_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43215-1

  • Online ISBN: 978-3-319-43217-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation